Holen Sie sich die Stockscreener-App
2.43
0.71%
-0.0174
Handel nachbörslich:
2.43
Schlusskurs vom Vortag:
$2.4474
Offen:
$2.43
24-Stunden-Volumen:
6,374
Relative Volume:
0.82
Marktkapitalisierung:
$10.13M
Einnahmen:
$33.36M
Nettoeinkommen (Verlust:
$-10.83M
KGV:
-7.8387
EPS:
-0.31
Netto-Cashflow:
$-5.54M
1W Leistung:
+0.00%
1M Leistung:
-4.71%
6M Leistung:
-18.05%
1J Leistung:
-19.27%
1-Tages-Spanne:
$2.39
$2.56
1-Wochen-Bereich:
$2.2934
$2.56
52-Wochen-Spanne:
$2.10
$3.80
Strata Skin Sciences Inc Stock (SSKN) Company Profile
Firmenname
Strata Skin Sciences Inc
Sektor
Branche
Telefon
215-619-3200
Adresse
5 WALNUT GROVE DRIVE, HORSHAM, PA
Vergleichen Sie SSKN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SSKN
Strata Skin Sciences Inc
|
2.43 | 10.39M | 33.36M | -10.83M | -5.54M | -0.31 |
|
ABT
Abbott Laboratories
|
133.58 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Strata Skin Sciences Inc Stock (SSKN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-12-09 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-10 | Eingeleitet | Northland Capital | Outperform |
| 2017-05-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-02-21 | Fortgesetzt | Rodman & Renshaw | Buy |
Strata Skin Sciences Inc Aktie (SSKN) Neueste Nachrichten
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Up 26.3% in May - Defense World
Vitiligo Pipeline 2025: Therapies, MOA Insights, and Key - openPR.com
Vitiligo Treatment Market Size, Share & Forecast 2024-2031 | - openPR.com
STRATA Skin Sciences (NASDAQ:SSKN) Stock Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
STRATA Skin Sciences Expands Access to Excimer Laser Treatments with CPT Code Updates - MSN
STRATA Skin Sciences Reports Q1 2025 Financial and Operational Progress - MSN
Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail
STRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory Diseases - Nasdaq
SSKN Gains Approval Expansion for Excimer Laser Treatments | SSKN Stock News - GuruFocus
STRATA Skin Sciences Announces Historic Expansion of CPT - GlobeNewswire
Major Medicare Victory: STRATA's Skin Treatment Now Covers 30M Patients After Historic CPT Code Expansion - Stock Titan
Strata Skin Sciences outlines multi-quarter Elevate 360 expansion as recurring revenue per device rises for fourth consecutive quarter - MSN
STRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor Call - MSN
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call Transcript - Insider Monkey
STRATA Skin Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
STRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYC - MSN
STRATA Skin Sciences Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: STRATA Skin Sciences sees modest growth in Q1 2025 - Investing.com Canada
Strata Skin Sciences Reports Q1 2025 Financial Results - TipRanks
STRATA Skin Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Strata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
A Peek at Strata Skin Sciences's Future Earnings - Nasdaq
STRATA Skin Sciences (SSKN) Projected to Post Quarterly Earnings on Wednesday - Defense World
STRATA Skin Sciences Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView
Vertex, Inc. Reports Strong First-Quarter Growth Driven by Cloud Revenue and Strategic Investments - MyChesCo
Innovative Solutions & Support Announces Q2 2025 Results and Investor Call Details - MyChesCo
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference - GlobeNewswire
Strata Skin Sciences To Report First Quarter 2025 Financial Results On May 14, 2025 And Provide Corporate Update - marketscreener.com
STRATA Skin Sciences, Inc. to Report First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update - GlobeNewswire
Cohen & Company to Announce Q1 2025 Financial Results on May 1 with Live Webcast - MyChesCo
Press Release Distribution & PR Platform - ACCESS Newswire
Facial Rejuvenation Market Report 2025-2034: Industry - openPR.com
Aesthetic Lasers Market Is Booming So Rapidly | Lumenis, Viora, Sciton - openPR.com
Dermatology Excimer Laser Market Size to Hit USD 1,725.35 Million by 2034 - Precedence Research
Vertex, Inc. to Announce Q1 2025 Financial Results on May 7 - MyChesCo
Radian Group Inc. Announces Q1 2025 Earnings Call - MyChesCo
Study Validates Advantages of STRATA Skin Sciences’ XTRAC Laser Technology - MSN
The Evolution of Dermatology Devices Market: What to Expect in 2025 - WhaTech
Dermatology Excimer Laser Market Size & Share Report, 2034 - Global Market Insights
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call Transcript - MSN
STRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
STRATA Skin Sciences revenue up 10% to USD 9.6 million in Q4 2024 - Medical Buyer
STRATA Skin Sciences Reports Strong Q4 Growth and Strategic Progress - MSN
Finanzdaten der Strata Skin Sciences Inc-Aktie (SSKN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Strata Skin Sciences Inc-Aktie (SSKN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Accelmed Partners, L.P. | 10% Owner |
Jul 15 '24 |
Buy |
3.14 |
230,573 |
723,999 |
1,441,835 |
| Rafaeli Dolev | Chief Executive Officer |
Jul 15 '24 |
Buy |
3.14 |
19,100 |
59,974 |
143,156 |
0.56%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):